Skip to search formSkip to main contentSkip to account menu

semaglutide

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Glucagon-Like Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
SAT-140 A Drug-Drug Interaction Trial of Oral Semaglutide with Levothyroxine and Multiple Coadministered Tablets
Abstract Introduction: Oral semaglutide contains the GLP-1 analog semaglutide co-formulated with the absorption enhancer, sodium… 
Review
2018
Review
2018
The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License… 
Review
2018
Review
2018
Corrigendum to "Pharmacotherapy for NASH: Current and emerging" [J Hepatol 68 (2017) 362-375].
Review
2017
Review
2017
Perspectives on cardiovascular effects of incretin-based drugs: From bedside to bench, return trip.
Review
2017
Review
2017
Cardiovascular disease leads to a new algorithm for diabetes treatment.
Review
2017
Review
2017
SAVOR-TIMI to SUSTAIN-6: a critical comparison of cardiovascular outcome trials of antidiabetic drugs
ABSTRACT Introduction: Since the inception of mandatory cardiovascular (CV) safety outcome trial (CVOT) promulgated by US FDA in… 
2017
2017
Semaglutide, reduction in HbA1c and the risk of diabetic retinopathy:
Authors: Tina Vilsbøll MD DMSc1, Stephen C. Bain FRCP2, Lawrence A. Leiter MD3, Ildiko Lingvay MD MPH4, David Matthews DPhil5… 
2017
2017
Semaglutide-the "new kid on the block" in the field of glucagon-like peptide-1 receptor agonists?
It is a known fact that, due to the progressive nature of type 2 diabetes (T2D) and decline of beta cell function, diabetes… 
2016
2016
Efficacy and Safety of Semaglutide Once-Weekly vs. Placebo as Add-on to Basal Insulin Alone or in Combination with Metformin in Subjects with Type 2 Diabetes (SUSTAIN 5)
2015
2015
Cardiovascular effects of the incretin-based therapy: the good, the bad, or the ugly?
Incretin hormones are secreted from enteronendocrine cells mainly upon nutrient absorption from the gut lumen. So far, two… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)